Walleye Capital
PRVA icon

Walleye Capital’s Privia Health PRVA Stock Holding History

Walleye Capital’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,397
Closed -$209K – 5002
2025
Q3 		$209K Buy
+8,397
New +$181K ﹤0.01% 3291
2023
Q4 		– Sell
-60,612
Closed -$1.39M – 5391
2023
Q3 		$1.39M Buy
+60,612
New +$1.54M ﹤0.01% 2001
2023
Q1 		– Sell
-19,138
Closed -$435K – 4281
2022
Q4 		$435K Buy
19,138
+7,108
+59% +$198K 0.01% 1544
2022
Q3 		$410K Buy
+12,030
New +$445K 0.01% 1601
2022
Q2 		– Sell
-12,341
Closed -$330K – 2664
2022
Q1 		$330K Sell
12,341
-19
-0.2% -$449 0.01% 1259
2021
Q4 		$320K Buy
+12,360
New +$308K 0.01% 1218

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's PRVA Position: Q4 2025 in Review

Walleye Capital sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 8,397 shares — an estimated $209K sold.

Walleye Capital first reported a position in PRVA in Q4 2021 and held it in 6 quarters. The position peaked at $1.39M in Q3 2023. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Walleye Capital reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 8,397 Privia Health shares in Q4 2025, an estimated $209K.
  • Walleye Capital first reported a position in Privia Health in Q4 2021 and held it in 6 quarters.
  • Walleye Capital's Privia Health position peaked at $1.39M in Q3 2023.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.